McKesson Corporation, Cardinal Health and Amerisource Bergen Drug, the three largest US drug distributors, have agreed to pay up to $1.18bn to settle the ongoing opioid-related case with The post Three US drug distributors agree to pay $1.18bn to settle opioid case in New York appeared first on Pharmaceutical Business review. … [Read more...]

Pfizer and BioNTech have signed a letter of intent with The Biovac Institute, the South African biopharmaceutical company, to jointly manufacture and distribute their Covid-19 Vaccine in the The post Biovac partners with Pfizer and BioNTech to manufacture Covid-19 vaccine appeared first on Pharmaceutical Business review. … [Read more...]

AstraZeneca has completed the acquisition of biopharmaceutical company Alexion Pharmaceuticals in a deal valued at $39bn. The latest move comes after the receipt of clearance from the UK The post AstraZeneca completes acquisition of biopharmaceutical firm Alexion appeared first on Pharmaceutical Business review. … [Read more...]

Pfizer and Arvinas have collaborated to co-develop and co-commercialise ARV-471, an investigational oral Protac estrogen receptor protein degrader. The estrogen receptor (ER) is a well-known disease driver in The post Pfizer and Arvinas to jointly develop and commercialise breast cancer drug appeared first on Pharmaceutical Business review. … [Read more...]

Merck and Eisai have secured approval from the US Food and Drug Administration (FDA) for Keytruda (pembrolizumab) plus Lenvima (lenvatinib) combination to treat patients with certain types of The post FDA approves Merck, Eisai’s Keytruda and Lenvima combination for endometrial cancer appeared first on Pharmaceutical Business review. … [Read more...]